Back
Corcept Therapeutics 10K Form
Buy
62
CORT
Corcept Therapeutics
Last Price:
$52.12
Seasonality Move:
6.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | CORT/Corcept Therapeutics Quarterly |
| 2023-11-01 | 10Q | CORT/Corcept Therapeutics Quarterly |
| 2023-08-02 | 10Q | CORT/Corcept Therapeutics Quarterly |
| 2023-05-03 | 10Q | CORT/Corcept Therapeutics Quarterly |
| 2022-11-03 | 10Q | CORT/Corcept Therapeutics Quarterly |
| 2022-08-04 | 10Q | CORT/Corcept Therapeutics Quarterly |
Receive CORT News And Ratings
See the #1 stock for the next 7 days that we like better than CORT
CORT Financial Statistics
Sales & Book Value
| Annual Sales: | $482.4M |
|---|---|
| Cash Flow: | $72.2M |
| Price / Cash Flow: | 39.77 |
| Annual Sales: | $6.10 |
| Price / Book: | 8.35 |
Profitability
| EPS (TTM): | 1.26000 |
|---|---|
| Net Income (TTM): | $141.8M |
| Gross Margin: | $475.9M |
| Return on Equity: | 25.77% |
| Return on Assets: | 21.04% |
Corcept Therapeutics Earnings Forecast
Key Corcept Therapeutics Financial Ratios
-
The Gross Profit Margin over the past 19 years for CORT is 98.66%.
-
The Selling, General & Administrative Expenses for CORT have been equal to 38.20% of Gross Profit Margin.
-
The Research & Development expenses have been 38.22% of Revenue.
-
The Interest Expense is 0.04% of Operating Income.
-
The Net Earning history of CORT is 22.00% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 12 years.
Corcept Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CORT |
| CUSIP: | 218352 |
| Website: | corcept.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.7 |
| Quick Ratio: | 3.49 |
Price-to-Earnings
| Trailing P/E Ratio: | 54.15 |
|---|---|
| Forward P/E Ratio: | 30.54 |
CORT Technical Analysis vs Fundamental Analysis
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $50.90. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.